An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
about
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogensA novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicityProtection of non-human primates against rabies with an adenovirus recombinant vaccine.A novel oncolytic adenovirus based on simian adenovirus serotype 24The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses.The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustionActivated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft ModelsHexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 InfectionGene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab.Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination.Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge.Development of Novel Vaccines Against Infectious Diseases Based on Chimpanzee Adenoviral Vector.Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines.A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.Vaccine Design: Replication-Defective Adenovirus Vectors.Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.Development of novel vaccine vectors: Chimpanzee adenoviral vectors.Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors.A fluorogenic 2D glycosheet for the simultaneous identification of human- and avian-receptor specificity in influenza viruses
P2860
Q26750912-519ACC9A-A5D7-4016-99C5-2DDE7C5AE528Q28727030-74CAF76D-0FC0-4981-9C12-38E8C18CFDD6Q33684288-BEF0EECC-05A6-4942-8513-D7997B90A891Q33688856-A400A034-08DB-4564-8833-076350501B71Q34341345-4FF220F6-B08F-4A28-8509-6443DBC1C4A3Q34626229-1403F059-060A-498D-A95E-AC207C95D985Q34985353-36E9EA38-6CF5-45AD-845E-083C8C6F994CQ35694238-7EA6AE20-DB7C-4154-B131-46DAA22CF6BAQ36659279-F476D520-C931-4CA6-91FE-191BE39D69BFQ37238922-3CA5415F-1E9C-41C7-B0D8-4C1625875C2FQ37317530-AAD5A8E7-4B8A-4118-8D60-BC9AF1EF2F64Q37546314-09C200D7-BEED-4325-B780-000737EC01DFQ37610184-77FABF4B-AC49-4F4A-8CDD-1F14E0F879CFQ37713951-A069F49A-328F-4056-8E49-38C3682C4DBFQ37718956-498A5BA2-FFB1-488A-877D-3544AFBA281CQ38891676-0B2F2D2F-F8CA-453E-A632-596D74017E48Q40259665-92D8D059-060B-4F29-A938-E9A3E40ACB9EQ40366453-68D8CEDC-8DE2-458D-A6F2-48D750ABA761Q40548641-874B4423-7E53-4E2D-8D37-A4F64730E187Q40801619-33F355F2-6D9D-43BE-8A10-0720D8CC58EAQ41335764-31157479-9F07-46F8-BBFD-525BF7D2EF78Q47202176-B23C958F-4A44-4115-A9AC-E57F86BAB157Q47558190-9484AE3E-26B6-4A32-AA46-54320DACA63EQ47558367-58114F77-4FC4-42D7-9802-B32FF02A4A7CQ48022505-46E5D043-A078-4273-BDA2-8495B2F3A9A0Q53692345-31BCFC52-0716-4058-AE03-B6F89C3F6982Q57760684-1AC901E0-B76A-4610-B810-DB7DABDAA3D8
P2860
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@en
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@nl
type
label
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@en
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@nl
prefLabel
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@en
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@nl
P2093
P2860
P356
P1433
P1476
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
@en
P2093
Dongming Zhou
Hildegund C J Ertl
Juliana C Small
Wynetta Giles-Davis
Xiangyang Zhou
Zhiquan Xiang
P2860
P2888
P304
P356
10.1038/NPROT.2010.134
P577
2010-10-14T00:00:00Z